Skip to content

Clinical trials

Phase 3 Atrial Fibrillation trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atrial Fibrillation Phase: Phase 3 Country / region: Netherlands Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20021
20034
20052
20062
20073
20083
20101
20121
20131
20143
20161
20172
20181
20222
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23
Terminated6
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi10
Boehringer Ingelheim3
Daiichi Sankyo3
Bayer2
Advanz Pharma1
Atrial Fibrillation Network1
Bristol-Myers Squibb1
CSL Behring1
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company1
Forest Laboratories1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atrial Fibrillation31
Stroke6
Arrhythmias, Cardiac3
Atrial Flutter3
Cardiovascular Diseases2
Embolism2
Heart Diseases2
Acute Coronary Syndrome1
Atherosclerosis1
Coronary Artery Disease1

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.